Company Filing History:
Years Active: 1998-2003
Title: Frederic Jaisser: Innovator in Gene Replacement Technologies
Introduction
Frederic Jaisser is a notable inventor based in Malakoff, France. He has made significant contributions to the field of genetic engineering, particularly in the area of gene replacement and conversion techniques. With a total of two patents to his name, Jaisser's work has the potential to advance research in embryonic stem cell applications.
Latest Patents
Jaisser's latest patents include innovative methods for introducing heterologous DNA sequences into mouse embryonic stem cells. The first patent, titled "I-Sce I induced gene replacement and gene conversion in embryonic stem cells," describes a technique that utilizes homologous recombination to insert DNA sequences into a villin gene/I-SceI hybrid. This method allows for the generation of transgenic mice that carry the desired genetic modifications. The second patent, "I Sce I-induced gene replacement and gene conversion in embryonic stem," focuses on constructing a villin gene hybrid by strategically inserting an I-Sce I restriction site. This insertion enhances the frequency of homologous recombination events, making it a valuable tool for transfecting eukaryotic cells, especially embryonic stem cells.
Career Highlights
Frederic Jaisser has worked with prestigious institutions such as Institut Pasteur and Institut Curie. His experience in these renowned research environments has contributed to his expertise in genetic engineering and stem cell research.
Collaborations
Throughout his career, Jaisser has collaborated with esteemed colleagues, including Michel Cohen-Tannoudji and Sylvie Robine. These partnerships have likely enriched his research and expanded the impact of his inventions.
Conclusion
Frederic Jaisser's innovative work in gene replacement technologies positions him as a significant figure in the field of genetic engineering. His patents reflect a commitment to advancing scientific knowledge and applications in embryonic stem cell research.